Telix Pharmaceuticals | TLX - Sales Revenues

Stock Price
10.00
Daily Change
-0.20 -1.96%
Monthly
-14.16%
Yearly
-64.86%
Q1 Forecast
10.21

Telix Pharmaceuticals reported AUD413.44M in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Cochlear AUD 585.65M 586.15M Jun/2025
CSL USD 3.54B 4.68B Jun/2025
Integral Diagnostics AUD 238.44M 7.19M Jun/2024
Mayne Pharma AUD 212.07M 17.03M Dec/2025
Medical Developments International AUD 9.53M 1.99M Jun/2025
Mesoblast USD 51.34M 38.14M Dec/2025
Neuren Pharmaceuticals AUD 14.14M 179.96M Jun/2025
Pacific Edge NZD 5.94M 4.95M Dec/2025
Paradigm Biopharmaceuticals AUD -8K 441.66K Jun/2025
Polynovo AUD 70.33M 35.75M Dec/2025
PYC Therapeutics AUD 13.48M 786.97K Jun/2025
Ramsay Health Care AUD 9.29B 32.2M Dec/2025
ResMed USD 1.42B 87.23M Dec/2025
Sonic Healthcare AUD 5.45B 470M Dec/2025